Clinical Efficacy and Safety of Risankizumab for the Treatment of Moderate to…
- Resource Type
- Journal
- Language
- Korean
- Region
- Korea
- Price
- $68.00
- Article Title
- Clinical Efficacy and Safety of Risankizumab for the Treatment of Moderate to Severe Psoriasis in Korea
- Publication
- Korean Journal of Dermatology
- ISSN
- 0494-4739
- Volume
- 61
- Issue
- 6
- Year
- 2023
- Pages
- 360-367
- Data Format
- Subject Fields
- Dermatology
- Note
- Full text is usually delivered within 1-2 hours
